8-K

II-VI Incorporated

Date: August 24, 2022

/s/ Mary Jane Raymond

Mary Jane Raymond

Chief Financial Officer and Treasurer

Exhibit 99.1

II-VI Incorporated Reports Q4 and Full-Year Fiscal 2022 Results

•

Delivers record quarterly revenues of $887 million, up 7% sequentially and 10% year-over-year

•

Posts Q4FY22 GAAP EPS of $0.23 and non-GAAP diluted EPS of $0.98

•

Achieves record FY22 bookings of $4.32 billion and revenue of $3.32 billion; up 29% and 7% annually respectively

•

Generates operating cash flow of $413 million

PITTSBURGH, Aug. 24, 2022 (GLOBE NEWSWIRE) — II-VI Incorporated (Nasdaq: IIVI) (“II-VI,” “We” or the “Company”) an innovator in materials, networking and lasers enabling a sustainable world, today reported results for its fiscal 2022 fourth quarter and fiscal year ended June 30, 2022.

The Company revenue for the fourth fiscal quarter of 2022 was $887 million, an increase of 7% over the third quarter of 2022 and an increase of 10% over the fourth quarter of fiscal year 2021, over the top end of the company’s guidance. Operating income for the fourth fiscal quarter of FY22 was $114 million with diluted earnings per share of $0.23 on a GAAP basis. On a non-GAAP basis, operating income was $169 million with non-GAAP diluted earnings per share of $0.98. For fiscal year 2022, revenue was $3.32 billion with GAAP diluted earnings per share of $1.45. Non-GAAP diluted earnings per share for fiscal year 2022 was $3.72.

“II-VI set new records for quarterly revenue in the fourth quarter and significant quarterly growth year-over-year, in response to sustained robust demand across our businesses, and despite a challenging operating environment,” said Dr. Vincent D. Mattera, Jr., Chair and CEO.

“Our strong performance throughout the year accelerated into the fourth quarter with strong demand thanks to our deep customer relationships, decades of investments in technology and sophisticated manufacturing platforms and leading-edge products. Leveraging our vertically integrated operations and global footprint, we continue to navigate a complex supply environment and capture expanding opportunities across end markets. We continue our selective investments in capacity expansion and next-generation technology and product development as we drive continued leadership and sustainable growth across all our end markets.

Dr. Mattera continued, “On September 8, 2022, we will transition to our new name, Coherent Corp., launch our new brand, and begin trading with a new ticker symbol (Nasdaq: COHR), signaling an exciting new era for the Company and all our employees, investors, and other stakeholders.”

T. 724.352.4455 | ii-vi.com

Page 1

Table 1

Financial Metrics

$ Millions, except per share amounts and %

(Unaudited)



	Three Months Ended									Year Ended
	Jun 30, 2022			Mar 31, 2022			Jun 30, 2021			Jun 30, 2022			Jun 30, 2021
Revenues	$	887.0		$	827.7		$	808.0		$	3,316.6		$	3,105.9

GAAP Gross Profit⁽³⁾	$	326.0		$	321.7		$	297.8		$	1,265.5		$	1,177.5
Non-GAAP Gross Profit⁽²⁾	$	343.4		$	335.7		$	311.7		$	1,321.5		$	1,235.0

GAAP Operating Income⁽¹⁾	$	114.2		$	106.8		$	97.1		$	414.3		$	402.1
Non-GAAP Operating Income⁽²⁾	$	168.6		$	172.0		$	148.5		$	650.2		$	601.5

GAAP Net Earnings	$	43.6		$	49.0		$	82.3		$	234.8		$	297.6
Non-GAAP Net Earnings⁽²⁾	$	133.7		$	129.0		$	117.0		$	504.6		$	460.2

GAAP Diluted Earnings Per Share	$	0.23		$	0.28		$	0.59		$	1.45		$	2.37
Non-GAAP Diluted Earnings Per Share⁽²⁾	$	0.98		$	0.95		$	0.88		$	3.72		$	3.73

Other Selected Financial Metrics
GAAP Gross margin⁽³⁾		36.8	%		38.9	%		36.9	%		38.2	%		37.9	%
Non-GAAP gross margin⁽²⁾		38.7	%		40.6	%		38.6	%		39.8	%		39.8	%
GAAP Operating margin		12.9	%		12.9	%		12.0	%		12.5	%		12.9	%
Non-GAAP operating margin⁽²⁾		19.0	%		20.8	%		18.4	%		19.6	%		19.4	%
GAAP Return on sales		4.9	%		5.9	%		10.2	%		7.1	%		9.6	%
Non-GAAP return on sales⁽²⁾		15.1	%		15.6	%		14.5	%		15.2	%		14.8	%

(1)	GAAP Operating income is defined as earnings before income taxes, interest expense and other expense or income, net.

(2)

All non-GAAP amounts exclude certain adjustments for share-based compensation, acquired intangible amortization expense, expenses incurred in relation to the Coherent acquisition as well as integration and restructuring charges from the Finisar acquisition, start-up costs, and various one-time adjustments. See Table 4 for the Reconciliation of GAAP measures to non-GAAP measures.

(3)	GAAP gross profit basis for prior periods has been updated to include amortization of developed technology intangible assets, with a corresponding decrease to selling, general and administrative on GAAP basis.

T. 724.352.4455 | ii-vi.com

Page 2

Outlook

The outlook for the first fiscal 2023 quarter ending September 30, 2022 is revenue of $1,300 million to $1,400 million and earnings per diluted share on a non-GAAP basis of $0.77 to $0.90. These are at today’s exchange rate and today’s estimated tax impact of 25%, both of which are subject to variability. The non-GAAP earnings per share include the pre-tax amounts of $65 million in amortization, $30 million in share-based compensation, and $170 million in other costs, including costs to facilitate the integration of Coherent Inc. Non-GAAP adjustments are by their nature highly volatile, and we have low visibility as to the range that may be incurred in the future.

Conference Call & Webcast Information

The Company will host a conference call at 9:00 a.m. Eastern Time on Wednesday August 24, 2022 to discuss these results. Individuals wishing to participate in the webcast can access the event at the Company’s web site by visiting www.ii-vi.com or via this link. Equity analysts and others who wish to participate in the question-and-answer session of the conference call can pre-register at this link to receive dial-in numbers and a unique PIN.

The conference call will be recorded, and a replay will be available to interested parties who are unable to attend the live event. This service will be available on the company’s website beginning August 24, 2022, at 4:00 p.m. ET.

About II-VI Incorporated

II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in communications, materials processing, aerospace & defense, semiconductor capital equipment, life sciences, consumer electronics, and automotive markets. Headquartered in Saxonburg, Pennsylvania, U.S.A., the Company has research and development, manufacturing, sales, service, and distribution facilities worldwide. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to support our customers. For more information, please visit us at www.ii-vi.com

Forward-looking Statements

This press release contains forward-looking statements relating to future events and expectations that are based on certain assumptions and contingencies. The forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The forward-looking statements in this press release involve risks and uncertainties, which could cause actual results, performance or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures.

The Company believes that all forward-looking statements made by it in this press release have a reasonable basis, but there can be no assurance that management’s expectations, beliefs, or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and global economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this press release include but are not limited to: (i) the failure of any one or more of the assumptions stated herein to prove to be correct; (ii) the risks relating to forward-looking statements and other “Risk Factors” discussed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021 and additional risk factors that may be identified from time to time in filings of the Company; (iii) the substantial indebtedness the Company incurred in connection with its acquisition of Coherent, Inc. (the “Transaction”) and the need to generate sufficient cash flows to service and repay such debt; (iv) the possibility that the Company may be unable to achieve expected synergies, operating efficiencies and other benefits within the expected time-frames or at all and to successfully integrate operations of Coherent, Inc. (“Coherent”) with those of the Company; (v) the possibility that such integration may be more difficult, time-consuming or costly than expected or that operating costs and business disruption (including, without limitation, disruptions in relationships with employees, customers or suppliers) may be greater than expected in connection with the Transaction; (vi) any unexpected costs, charges or expenses resulting

T. 724.352.4455 | ii-vi.com

Page 3

from the Transaction; (vii) the risk that disruption from the Transaction materially and adversely affects the respective businesses and operations of the Company and Coherent; (viii) potential adverse reactions or changes to business relationships resulting from the completion of the Transaction; (ix) the ability of the Company to retain and hire key employees; (x) the purchasing patterns of customers and end users; (xiii) the timely release of new products, and acceptance of such new products by the market; (xi) the introduction of new products by competitors and other competitive responses; (xii) the Company’s ability to assimilate recently acquired businesses, and realize synergies, cost savings, and opportunities for growth in connection therewith, together with the risks, costs, and uncertainties associated with such acquisitions; (xiii) the Company’s ability to devise and execute strategies to respond to market conditions; (xiv) the risks to realizing the benefits of investments in R&D and commercialization of innovations; (xv) the risks that the Company’s stock price will not trade in line with industrial technology leaders; and/or (xvi) the risks of business and economic disruption related to the currently ongoing COVID-19 outbreak and any other worldwide health epidemics or outbreaks that may arise. The Company disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events or developments, or otherwise.

Use of Non-GAAP Financial Measures

The Company has disclosed financial measurements in this press release that present financial information considered to be non-GAAP financial measures. These measurements are not a substitute for GAAP measurements, although the Company’s management uses these measurements as an aid in monitoring the Company’s on-going financial performance. The non-GAAP net earnings, the non-GAAP earnings per share, the non-GAAP operating income, the non-GAAP gross profit, the non-GAAP internal research and development, the non-GAAP selling, general and administration, the non-GAAP interest and other (income) expense, and the non-GAAP income tax (benefit), measure earnings and operating income (loss), respectively, excluding non-recurring or unusual items that are considered by management to be outside the Company’s standard operation and excluding certain non-cash items. EBITDA is an adjusted non-GAAP financial measurement that is considered by management to be useful in measuring the profitability between companies within the industry by reflecting operating results of the Company excluding non-operating factors. There are limitations associated with the use of non-GAAP financial measures, including that such measures may not be entirely comparable to similarly titled measures used by other companies, due to potential differences among calculation methodologies. Thus, there can be no assurance whether (i) items excluded from the non-GAAP financial measures will occur in the future or (ii) there will be cash costs associated with items excluded from the non-GAAP financial measures. The Company compensates for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by providing the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures. Investors should consider adjusted measures in addition to, and not as a substitute for, or superior to, financial performance measures prepared in accordance with GAAP.

T. 724.352.4455 | ii-vi.com

Page 4

II-VI Incorporated and Subsidiaries

Condensed Consolidated Statements of Earnings (Unaudited)

($000 except per share data)



	Three Months Ended
	June 30, 2022		March 31, 2022		June 30, 2021
Revenues	$	886,962	$	827,724	$	808,006

Costs, Expenses & Other Expense (Income)
Cost of goods sold		560,930		506,051		510,213
Internal research and development		95,917		96,895		83,768
Selling, general and administrative		115,862		118,009		116,832
Interest expense		48,502		43,499		14,066
Other expense (income), net		16,768		241		(10,124	)

Total Costs, Expenses, & Other Expense (Income)		837,979		764,695		714,755

Earnings Before Income Taxes		48,983		63,029		93,251

Income Taxes		5,347		14,027		10,957

Net Earnings	$	43,636	$	49,002	$	82,294

Less: Dividends on Preferred Stock		17,291		17,148		16,878

Net Earnings available to the Common Shareholders	$	26,345	$	31,854	$	65,416

Basic Earnings Per Share	$	0.25	$	0.30	$	0.62

Diluted Earnings Per Share	$	0.23	$	0.28	$	0.59

Average Shares Outstanding — Basic		106,520		106,323		104,957
Average Shares Outstanding — Diluted		116,821		116,949		116,225

T. 724.352.4455 | ii-vi.com

Page 5

II-VI Incorporated and Subsidiaries

Condensed Consolidated Statements of Earnings (Unaudited)

($000 except per share data)


	Year Ended
	June 30, 2022		June 30, 2021
Revenues	$	3,316,616	$	3,105,891

Costs, Expenses & Other Expense (Income)
Cost of goods sold		2,051,120		1,928,432
Internal research and development		377,106		330,105
Selling, general and administrative		474,096		445,235
Interest expense		121,254		59,899
Other expense (income), net		11,233		(10,370	)

Total Costs, Expenses, & Other Expense (Income)		3,034,809		2,753,301

Earnings Before Income Taxes		281,807		352,590

Income Taxes		47,048		55,038

Net Earnings	$	234,759	$	297,552

Less: Dividends on Preferred Stock		68,225		37,231

Net Earnings available to the Common Shareholders		166,534		260,321

Basic Earnings Per Share	$	1.57	$	2.50

Diluted Earnings Per Share	$	1.45	$	2.37

Average Shares Outstanding — Basic		106,189		104,151
Average Shares Outstanding — Diluted		116,513		115,034

T. 724.352.4455 | ii-vi.com

Page 6

II-VI Incorporated and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

($000)


	June 30, 2022		June 30, 2021
Assets
Current Assets
Cash, cash equivalents, and restricted cash	$	2,582,371	$	1,591,892
Accounts receivable		700,331		658,962
Inventories		902,559		695,828
Prepaid and refundable income taxes		19,585		13,095
Prepaid and other current assets		100,346		67,617

Total Current Assets		4,305,192		3,027,394
Property, plant & equipment, net		1,363,195		1,242,906
Goodwill		1,285,759		1,296,727
Other intangible assets, net		635,404		718,460
Deferred income taxes		31,714		33,498
Other assets		223,582		193,665

Total Assets	$	7,844,846	$	6,512,650

Liabilities, Mezzanine Equity and Shareholders’ Equity
Current Liabilities
Current portion of long-term debt	$	403,212	$	62,050
Accounts payable		434,917		294,486
Operating lease current liabilities		27,574		25,358
Accruals and other current liabilities		401,256		347,695

Total Current Liabilities		1,266,959		729,589
Long-term debt		1,897,214		1,313,091
Deferred income taxes		77,259		73,962
Operating lease liabilities		110,214		125,541
Other liabilities		109,922		138,119

Total Liabilities		3,461,568		2,380,302
Total Mezzanine Equity		766,803		726,178
Total Shareholders’ Equity		3,616,475		3,406,170

Total Liabilities, Mezzanine Equity and Shareholders’ Equity	$	7,844,846	$	6,512,650

T. 724.352.4455 | ii-vi.com

Page 7

II-VI Incorporated and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Unaudited)

($000)


	Year Ended June 30,
	2022			2021
Cash Flows from Operating Activities
Net cash provided by operating activities	$	413,332		$	574,353

Cash Flows from Investing Activities
Additions to property, plant & equipment		(314,332	)		(146,337	)
Purchases of businesses, net of cash acquired		—			(34,394	)
Other investing activities		(5,750	)		7,774

Net cash used in investing activities		(320,082	)		(172,957	)

Cash Flows from Financing Activities
Proceeds from issuance of Senior Notes		990,000			—
Proceeds from issuance of common shares		—			460,000
Proceeds from issuance of Series A preferred shares		—			460,000
Proceeds from issuance of Series B preferred shares		—			750,000
Payment on Finisar Notes		(14,888	)		—
Payments on borrowings under Term A Facility		(62,050	)		(137,050	)
Payments on borrowings under Term B Facility		—			(714,600	)
Payments on borrowings under Revolving Credit Facility		—			(74,000	)
Debt issuance costs		(10,197	)		—
Equity issuance costs		—			(58,596	)
Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan		17,858			32,360
Payments in satisfaction of employees’ minimum tax obligations		(21,249	)		(19,701	)
Payment of dividends		(34,508	)		(20,319	)
Other financing activities		(2,013	)		(2,367	)

Net cash provided by financing activities		862,953			675,727

Effect of exchange rate changes on cash, cash equivalents and restricted cash		34,276			21,723
Net increase in cash, cash equivalents and restricted cash		990,479			1,098,846
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period		1,591,892			493,046

Cash, Cash Equivalents, and Restricted Cash at End of Period	$	2,582,371		$	1,591,892

T. 724.352.4455 | ii-vi.com

Page 8

Table 2

Segment Revenues, GAAP Operating Income (Loss) & Margin, and

Non-GAAP Operating Income (Loss) & Margin*

$ Millions, except %

(Unaudited)


	Three Months Ended									Year Ended
	Jun 30, 2022			Mar 31, 2022			Jun 30, 2021			Jun 30, 2022			Jun 30, 2021
Revenues:
Photonic Solutions	$	597.4		$	567.8		$	549.7		$	2,226.2		$	2,038.3
Compound Semiconductors		289.6			259.9			258.3			1,090.4			1,067.6
Unallocated and Other		—			—			—			—			—

Consolidated	$	887.0		$	827.7		$	808.0		$	3,316.6		$	3,105.9

GAAP Operating Income (Loss):
Photonic Solutions	$	69.2		$	54.6		$	60.5		$	230.1		$	207.7
Compound Semiconductors		51.4			61.8			47.7			220.1			221.2
Unallocated and Other		(6.4	)		(9.6	)		(11.1	)		(35.9	)		(26.8	)

Consolidated	$	114.2		$	106.8		$	97.1		$	414.3		$	402.1

Non-GAAP Operating Income:
Photonic Solutions	$	91.7		$	81.8		$	87.4		$	334.4		$	324.3
Compound Semiconductors		76.9			90.2			61.1			315.8			277.2
Unallocated and Other		—			—			—			—			—

Consolidated	$	168.6		$	172.0		$	148.5		$	650.2		$	601.5

GAAP Operating Margin:
Photonic Solutions		11.6	%		9.6	%		11.0	%		10.3	%		10.2	%
Compound Semiconductors		17.7	%		23.8	%		18.5	%		20.2	%		20.7	%
Consolidated		12.9	%		12.9	%		12.0	%		12.5	%		12.9	%
Non-GAAP Operating Margin:
Photonic Solutions		15.3	%		14.4	%		15.9	%		15.0	%		15.9	%
Compound Semiconductors		26.6	%		34.7	%		23.7	%		29.0	%		26.0	%
Consolidated		19.0	%		20.8	%		18.4	%		19.6	%		19.4	%

*	“Unallocated and Other” primarily includes transaction costs related to the Coherent transaction.

T. 724.352.4455 | ii-vi.com

Page 9

Table 3

Reconciliation of Segment Non-GAAP Operating Income (Loss) to

GAAP Segment Operating Income (Loss)

$ Millions

(Unaudited)


	Three Months Ended									Year Ended
	Jun 30, 2022			Mar 31, 2022			Jun 30, 2021			Jun 30, 2022			Jun 30, 2021
Non-GAAP Photonic Solutions Operating Income	$	91.7		$	81.8		$	87.4		$	334.4		$	324.3
Share-based compensation		(3.1	)		(8.8	)		(9.4	)		(30.9	)		(39.6	)
Amortization of acquired intangibles		(16.6	)		(16.5	)		(17.3	)		(66.7	)		(69.2	)
Restructuring, transaction expenses and other		(2.8	)		(1.9	)		(0.2	)		(6.7	)		(7.8	)

Photonic Solutions GAAP Operating Income	$	69.2		$	54.6		$	60.5		$	230.1		$	207.7

Non-GAAP Compound Semiconductors Operating Income	$	76.9		$	90.2		$	61.1		$	315.8		$	277.2
Share-based compensation		(10.5	)		(9.2	)		(9.3	)		(42.2	)		(39.4	)
Amortization of acquired intangibles		(3.2	)		(2.9	)		(3.3	)		(12.9	)		(13.0	)
Restructuring, transaction expenses, and other		(5.4	)		(1.7	)		(0.8	)		(8.3	)		(3.6	)
Start-up costs	$	(6.4	)	$	(14.6	)	$	—		$	(32.3	)	$	—

Compound Semiconductors GAAP Operating Income	$	51.4		$	61.8		$	47.7		$	220.1		$	221.2

Non-GAAP Unallocated and Other Operating Income (Loss)	$	—		$	—		$	—		$	—		$	—
Restructuring, transaction expenses, and other		(6.4	)		(9.6	)		(11.1	)		(35.9	)		(26.8	)

Unallocated and Other GAAP Operating Income (Loss)	$	(6.4	)	$	(9.6	)	$	(11.1	)	$	(35.9	)	$	(26.8	)

Total GAAP Operating Income	$	114.2		$	106.8		$	97.1		$	414.3		$	402.1

Non-GAAP Operating Income	$	168.6		$	172.0		$	148.5		$	650.2		$	601.5

*	Amounts may not recalculate due to rounding.

T. 724.352.4455 | ii-vi.com

Page 10

Table 4

Reconciliation of GAAP Measures to non-GAAP Measures

$ Millions

(Unaudited)


	Three Months Ended									Year Ended
	Jun 30, 2022			Mar 31, 2022			Jun 30, 2021			Jun 30, 2022			Jun 30, 2021
Gross profit on GAAP basis	$	326.0		$	321.7		$	297.8		$	1,265.5		$	1,177.5
Share-based compensation		0.9			1.3			3.4			5.1			12.1
Amortization of acquired intangibles₍₄₎		9.6			9.4			9.8			38.3			38.8
Start-up costs ₍₃₎		—			1.6			—			2.8			—
Restructuring, transaction expenses and other ₍₁₎		6.9			1.7			0.7			9.8			6.7

Gross profit on non-GAAP basis	$	343.4		$	335.7		$	311.7		$	1,321.5		$	1,235.0

Internal research and development on GAAP basis	$	95.9		$	96.9		$	83.8		$	377.1		$	330.1
Share-based compensation		(1.3	)		(2.0	)		(4.8	)		(7.6	)		(17.0	)
Start-up costs ₍₃₎		(6.4	)		(13.0	)		—			(29.5	)		—
Restructuring, transaction expenses and other ₍₅₎		(0.6	)		—			—			(0.6	)		—

Internal research and development on non-GAAP basis	$	87.6		$	81.9		$	79.0		$	339.4		$	313.1

Selling, general and administrative on GAAP basis	$	115.9		$	118.0		$	116.8		$	474.1		$	445.2
Share-based compensation		(11.3	)		(14.9	)		(10.3	)		(60.4	)		(49.8	)
Amortization of acquired intangibles₍₄₎		(10.3	)		(10.0	)		(10.8	)		(41.4	)		(43.4	)
Restructuring, transaction expenses and other ₍₁₎		(7.1	)		(11.5	)		(11.5	)		(40.5	)		(31.6	)

Selling, general and administrative on non-GAAP basis	$	87.2		$	81.6		$	84.3		$	331.8		$	320.4

Operating income on GAAP basis	$	114.2		$	106.8		$	97.1		$	414.3		$	402.1
Share-based compensation		13.5			18.2			18.5			73.1			78.9
Start-up costs ₍₃₎		6.4			14.6			—			32.3			—
Amortization of acquired intangibles		19.9			19.4			20.6			79.7			82.2
Restructuring, transaction expenses and other ₍₁₎		14.6			13.2			12.2			50.9			38.3

Operating income on non-GAAP basis	$	168.6		$	172.0		$	148.5		$	650.2		$	601.5

T. 724.352.4455 | ii-vi.com

Page 11

Table 4

Reconciliation of GAAP Measures to non-GAAP Measures (Continued)

$ Millions

(Unaudited)


	Three Months Ended									Year Ended
	Jun 30, 2022			Mar 31, 2022			Jun 30, 2021			Jun 30, 2022			Jun 30, 2021
Interest and other (income) expense, net on GAAP basis	$	65.3		$	43.7		$	3.9		$	132.5		$	49.5
Foreign currency exchange losses		(19.8	)		(1.1	)		(1.2	)		(16.2	)		(5.5	)
Gain on investments		—			—			10.9			—			17.9
Debt extinguishment expense⁽²⁾		—			—			—			—			(24.7	)
Gain on preferred equity forward sale agreement		—			—			—			—			11.4
Restructuring, transaction expenses and other⁽¹⁾		(38.3	)		(33.3	)		—			(79.0	)		—

Interest and other (income) expense, net on non-GAAP basis	$	7.2		$	9.3		$	13.6		$	37.3		$	37.2

Income taxes on GAAP basis	$	5.3		$	14.0		$	11.0		$	47.0		$	55.0
Tax impact of non-GAAP measures		22.6			19.8			6.8			63.9			37.6

Income taxes on non-GAAP basis	$	27.9		$	33.8		$	17.8		$	110.9		$	92.6

Net earnings on GAAP basis	$	43.6		$	49.0		$	82.3		$	234.8		$	297.6
Share-based compensation		13.5			18.2			18.5			73.1			78.9
Amortization of acquired intangibles		19.9			19.4			20.6			79.7			82.2
Start-up costs⁽³⁾		6.4			14.6			—			32.3			—
Foreign currency exchange losses		19.8			1.1			1.2			16.2			5.5
Gain on investments		—			—			(10.9	)		—			(17.9	)
Debt extinguishment expense⁽²⁾		—			—			—			—			24.7
Restructuring, transaction expenses and other⁽¹⁾		53.0			46.6			12.2			132.3			26.9
Tax impact of non-GAAP measures		(22.6	)		(19.8	)		(6.8	)		(63.9	)		(37.6	)

Net earnings on non-GAAP basis	$	133.7		$	129.0		$	117.0		$	504.6		$	460.2

Per share data:
Net earnings on GAAP basis
Basic Earnings Per Share	$	0.25		$	0.30		$	0.62		$	1.57		$	2.50
Diluted Earnings Per Share	$	0.23		$	0.28		$	0.59		$	1.45		$	2.37

Net earnings on non-GAAP basis
Basic Earnings Per Share	$	1.09		$	1.05		$	0.95		$	4.11		$	4.06
Diluted Earnings Per Share	$	0.98		$	0.95		$	0.88		$	3.72		$	3.73

*	Amounts may not recalculate due to rounding.

During fiscal year 2022, restructuring, transaction expenses and other, primarily represent expenses incurred in relation to the Coherent acquisition as well as integration and restructuring charges from the Finisar acquisition, and various one-time adjustments. Incremental interest expense related to the financing for the Coherent transaction will be included as an adjustment in arriving at non-GAAP earnings for periods prior to transaction close, as the associated funding was contingent on transaction close. During fiscal year 2021, transaction costs primarily represent acquisition and integration costs related to the Ascatron and Innovion acquisitions, as well as customer settlements from acquired liabilities of previous acquisitions.

2.	The Company recorded debt extinguishment expense of $24.7 million in connection with the extinguishment of the Term B Loan Facility during the fiscal year ended June 30, 2021.

3.	Start-up costs in operating expenses incurred in the quarter were related to the start-up of new devices for new customer applications.

T. 724.352.4455 | ii-vi.com

Page 12

4.	GAAP gross profit basis for prior periods has been updated to include amortization of developed technology intangible assets, with a corresponding decrease to selling, general and administrative on GAAP basis.

T. 724.352.4455 | ii-vi.com

Page 13

Table 5

Reconciliation of GAAP Net Income (Loss), EBITDA and Adjusted EBITDA

$ Millions

(Unaudited)


	Three Months Ended									Year Ended
	Jun 30,			Mar 31,			Jun 30,			Jun 30,			Jun 30,
	2022			2022			2021			2022			2021
Net earnings on GAAP basis	$	43.6		$	49.0		$	82.3		$	234.8		$	297.6
Income taxes		5.3			14.0			10.9			47.0			55.0
Depreciation and amortization		73.3			72.8			70.2			286.8			270.1
Interest expense		48.5			43.5			14.1			121.3			59.9

EBITDA⁽¹⁾	$	170.7		$	179.3		$	177.5		$	689.9		$	682.6

EBITDA margin		19.2	%		21.7	%		22.0	%		20.8	%		22.0	%

Share-based compensation		13.5			18.2			18.5			73.1			78.9
Foreign currency exchange losses, net		19.8			1.1			1.2			16.2			5.5
Start-up costs		6.4			14.6			—			32.3			—
Debt extinguishment expense		—			—			—			—			24.7
Gain on investment		—			—			—			—			(7.0	)
Gain on preferred equity forward sale agreement		—			—			—			—			(11.4	)
Restructuring, transaction expenses, and other⁽³⁾		14.6			13.2			2.8			53.3			27.4

Adjusted EBITDA⁽²⁾	$	225.0		$	226.4		$	200.0		$	864.8		$	800.7

Adjusted EBITDA margin		25.4	%		27.4	%		24.8	%		26.1	%		25.8	%

*	Amounts may not recalculate due to rounding.

(1)	EBITDA is defined as earnings before interest, income taxes, depreciation and amortization.

(2)	Adjusted EBITDA excludes non-GAAP adjustments for share-based compensation, certain one-time transaction expense, the impact of restructuring and related items, and the impact of foreign currency exchange gains and losses.

(3)

T. 724.352.4455 | ii-vi.com

Page 14

Table 6

GAAP Earnings Per Share Calculation

$ Millions

(Unaudited)


	Three Months Ended									Year Ended
	Jun 30,			Mar 31,			Jun 30,			Jun 30,			Jun 30,
	2022			2022			2021			2022			2021
Numerator
Net earnings	$	43.6		$	49.0		$	82.3		$	234.8		$	297.6
Deduct Series A preferred stock dividends		(6.9	)		(6.9	)		(6.9	)		(27.6	)		(27.1	)
Deduct Series B dividends and deemed dividends		(10.4	)		(10.2	)		(10.0	)		(40.6	)		(10.1	)

Basic earnings available to common shareholders	$	26.3		$	31.9		$	65.4		$	166.5		$	260.3

Effect of dilutive securities
Add back interest on II-VI Convertible Notes (net of tax)	$	0.6		$	0.6		$	3.1		$	2.2		$	12.3

Diluted earnings available to common shareholders	$	26.9		$	32.4		$	68.5		$	168.8		$	272.6

Denominator
Weighted average shares		106.5			106.3			105.0			106.2			104.2
Effect of dilutive securities:
Common stock equivalents		3.0			3.3			3.9			3.0			3.6
II-VI Convertible Notes		7.3			7.3			7.3			7.3			7.3

Diluted weighted average common shares		116.8			116.9			116.2			116.5			115.0

Basic earnings per common share	$	0.25		$	0.30		$	0.62		$	1.57		$	2.50

Diluted earnings per common share	$	0.23		$	0.28		$	0.59		$	1.45		$	2.37

*	Amounts may not recalculate due to rounding.

T. 724.352.4455 | ii-vi.com

Page 15

Table 7

Non-GAAP Earnings Per Share Calculation

$ Millions

(Unaudited)



	Three Months Ended									Year Ended
	Jun 30,			Mar 31,			Jun 30,			Jun 30,			Jun 30,
	2022			2022			2021			2022			2021
Numerator
Net earnings on non-GAAP basis	$	133.7		$	129.0		$	117.0		$	504.6		$	460.2

Deduct Series A preferred stock dividends		(6.9	)		(6.9	)		(6.9	)		(27.6	)		(27.1	)
Deduct Series B redeemable preferred dividends		(10.4	)		(10.2	)		(10.0	)		(40.6	)		(10.1	)

Basic earnings available to common shareholders	$	116.4		$	111.9		$	100.2		$	436.3		$	423.0

Effect of dilutive securities

Add back interest on II-VI Convertible Notes	$	0.6		$	0.6		$	3.1		$	2.2		$	12.3
Add back Series A preferred stock dividends		6.9			6.9			6.9			27.6			27.1

Diluted earnings available to common shareholders	$	123.8		$	119.4		$	110.1		$	466.2		$	462.4

Denominator
Weighted average shares		106.5			106.3			105.0			106.2			104.2
Effect of dilutive securities:
Common stock equivalents		3.0			3.3			3.9			3.0			3.6
II-VI Convertible Notes		7.3			7.3			7.3			7.3			7.3
Series A Mandatory Convertible Preferred Stock		8.9			8.9			8.9			8.9			8.9

Diluted weighted average common shares		125.7			125.9			125.1			125.4			123.9

Basic earnings per common share on non-GAAP basis⁽¹⁾	$	1.09		$	1.05		$	0.95		$	4.11		$	4.06

Diluted earnings per common share on non-GAAP basis	$	0.98		$	0.95		$	0.88		$	3.72		$	3.73

*	Amounts may not recalculate due to rounding.

T. 724.352.4455 | ii-vi.com

Page 16

Table 8

Example EPS Calculations⁽¹⁾

$ Millions



	Hypothetical Earnings Level for Q1 FY23
Non-GAAP net earnings	$	145.0		$	155.0		$	165.0
Deduct Series A preferred stock dividends		(6.9	)		—			—
Deduct Series B redeemable preferred dividends		(28.7	)		(28.7	)		(28.7	)
Add back interest on II-VI Convertible Notes		0.4			0.4			0.4

Non-GAAP net earnings available to common shareholders	$	109.8		$	126.7		$	136.7

Diluted weighted average common shares		142.3			151.2			151.2
Diluted earnings per common share on non-GAAP basis	$	0.77		$	0.84		$	0.90

(1)

The Company does not provide reconciliations of the hypothetical non-GAAP net earnings and hypothetical diluted non-GAAP EPS presented in this table. This table contains purely hypothetical figures, which are provided solely to illustrate how the Company would calculate diluted non-GAAP EPS under different factual scenarios.

CONTACT:

Mary Jane Raymond

Treasurer and Chief Financial Officer

[email protected]

www.ii-vi.com/contact-us

T. 724.352.4455 | ii-vi.com

Page 17

August 24, 2022 Investor Presentation Exhibit 99.2

Forward-Looking Statements This presentation contains forward-looking statements relating to future events and expectations that are based on certain assumptions and contingencies. The forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going forward basis. The forward-looking statements in this presentation involve risks and uncertainties, which could cause actual results, performance or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. The Company believes that all forward-looking statements made by it in this presentation have a reasonable basis, but there can be no assurance that management’s expectations, beliefs, or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and global economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this presentation include but are not limited to: (i) the failure of any one or more of the assumptions stated herein to prove to be correct; (ii) the risks relating to forward-looking statements and other “Risk Factors” discussed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021 and additional risk factors that may be identified from time to time in filings of the Company; (iii) the substantial indebtedness the Company incurred in connection with its acquisition of Coherent, Inc. (the “Transaction”) and the need to generate sufficient cash flows to service and repay such debt; (iv) the possibility that the Company may be unable to achieve expected synergies, operating efficiencies and other benefits within the expected time-frames or at all and to successfully integrate operations of Coherent, Inc. (“Coherent”) with those of the Company; (v) the possibility that such integration may be more difficult, time-consuming or costly than expected or that operating costs and business disruption (including, without limitation, disruptions in relationships with employees, customers or suppliers) may be greater than expected in connection with the Transaction; (vi) any unexpected costs, charges or expenses resulting from the Transaction; (vii) the risk that disruption from the Transaction materially and adversely affects the respective businesses and operations of the Company and Coherent; (viii) potential adverse reactions or changes to business relationships resulting from the completion of the Transaction; (ix) the ability of the Company to retain and hire key employees; (x) the purchasing patterns of customers and end users; (xi) the timely release of new products, and acceptance of such new products by the market; (xii) the introduction of new products by competitors and other competitive responses; (xiii) the Company’s ability to assimilate recently acquired businesses, and realize synergies, cost savings, and opportunities for growth in connection therewith, together with the risks, costs, and uncertainties associated with such acquisitions; (xiv) the Company’s ability to devise and execute strategies to respond to market conditions; (xv) the risks to realizing the benefits of investments in R&D and commercialization of innovations; (xvi) the risks that the Company’s stock price will not trade in line with industrial technology leaders; and/or (xvi) the risks of business and economic disruption related to the currently ongoing COVID-19 outbreak and any other worldwide health epidemics or outbreaks that may arise. The Company disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events or developments, or otherwise. All information in this presentation is as of August 24, 2022. This presentation contains non-GAAP financial measures and key metrics relating to the Company’s past performance. These non-GAAP financial measures are in addition to, and not as a substitute for or superior to, measures of financial performance prepared in accordance with U.S. GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their nearest GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. As required by Regulation G, we have provided reconciliations of those measures to the most directly comparable GAAP measures, which are available in the Appendix.

Proforma revenue combines II-VI FY22 revenue (as of FYE 6/30/22) and Coherent 6/30/22 TTM. As of July 1, 2022 Vertically Integrated Model II-VI/Coherent Combination at a Glance 4,500+ Employees(2) 28,000+ Employees(2) 3,000+ Patents(2) Engineering & Technology FY22 Revenue(1) $4.8B Available Market(2) $65B 4 Markets(2) Industrial Communications Electronics Instrumentation 3 Segments(2) Materials Networking Lasers Effective September 8, 2022, II-VI Incorporated will be named Coherent Corp. and will trade under the ticker symbol COHR.

$4.8 Billion Proforma(1) Revenue in FY22 Proforma revenue combines II-VI FY22 revenue (as of FYE 6/30/22) and Coherent 6/30/22 TTM. II-VI Incorporated revenue by region is based on customer headquarter address; Coherent, Inc. revenue by region is based on customer ship to address. Communications Industrial By Market Electronics Instrumentation Networking By Reporting Segment Materials Lasers North America Asia Pacific By Region(2) Other Europe

Building Momentum for 50 Years One of the largest photonics and compound semiconductor companies Materials expertise drives differentiation in multiple growing markets Vertically integrated, diverse global manufacturing footprint History of insightful targeting and successful integration of strategic acquisitions Strong execution and resilient growth 1 2 3 4 5 II-VI rang the Nasdaq stock market opening bell in celebration of its 50th anniversary on June 22, 2021

Communications Industrial Q4 FY22 Financial Highlights(1) Semiconductor Capital Equipment Life Sciences Aerospace & Defense Consumer Electronics Japan Other North America Automotive & Other Revenue by Region(2) Revenue by End Market Revenue $887M China Europe Q4 FY22 GAAP Non-GAAP Operating Income $114.2M $168.6M Earnings Per Share $0.23 $0.98 Bookings $1.0B Backlog $2.3B II-VI standalone actuals as of June 30, 2022 II-VI Incorporated revenue by region is based on customer headquarter address

Attractive and Increasing Operating Margins All non-GAAP amounts exclude certain adjustments for share-based compensation, acquired intangible amortization expense, certain one-time transaction expenses, debt extinguishment expense, fair value measurement period adjustments and restructuring and related items. See Appendix for reconciliation to most comparable GAAP measures. II-VI figures are for the three months ended September 30, 2019 and Finisar figures are for the three months ended July 28, 2019. Strong Execution and Synergy Realization Post Finisar Transaction Close Driving Margins Non-GAAP Gross Margin(1) Non-GAAP Operating Margin(1) II-VI Last Quarter Before Close(2) II-VI Last Quarter Before Close(2)

History of Insightful Targeting and Successful Integration of Strategic Acquisitions 10 Years of Continuous Revenue Growth CAGR 20% 2010 - Optical networks & China market 2013 - Gallium arsenide technology platform 2016 - Epitaxial wafer and SiC electronic devices 2019 - Indium phosphide technology platform 2022 - Laser sources & systems 5 Transformative Acquisitions: Revenue(1) ($M) Figures prior to FY2019 do not reflect the adoption of ASC 606. Prepared in accordance to ASC 805. Pro Forma includes the revenue of Finisar in Q1FY20 prior to the acquisition date of 9/24/20. FY21 actual. See Appendix for reconciliation to most comparable GAAP measures. IIVI+COHR (Proforma)

Three Reporting Segments Materials Networking Lasers Innovations that resonate

Catalyzing Growth from Curiosity and Innovation Combined R&D and capex spend expected to be highest in industry and to accelerate breakthroughs, time-to-market and time-to-scale advantages Increased scale improves competitiveness and drives more strategic dialogue with customers Will enable better alignment of organic and inorganic investments to market demand Half a Billion Dollars in Annual R&D Investment “We are mainly constrained by the quality of our materials and the limits of our imaginations.” Dr. Carl J. Johnson, Co-founder and first CEO of II-VI

Simplifying and Strengthening our Focus on Four Markets with a Combined $65B in TAM Industrial Communications Electronics Instrumentation TAM: $28B CAGR: 13% TAM: $21B CAGR: 12% TAM: $11B CAGR: 17% TAM: $5B CAGR: 7% Note: TAM based on CY2022; CAGR based on 2022-27 timeframe. Sources: LightCounting, Omdia, Cignal AI, Yole, Internal Estimates Sources: Optech Consulting, Strategies Unlimited, SEMI, Internal Estimates Sources: Strategies Unlimited, Markets & Markets, SDI (Strategic Directions), Internal Estimates Sources: IDC, Morgan Stanley, Research & Markets, Forbes, Yole, Strategy Analytics, Internal Estimates

The Industrial Market 50 years of experience in laser technology Long term technology partner across all laser architectures Broadest spectrum of laser and systems technologies Productivity enhancement through innovation and knowhow Superior equipment and process quality Comprehensive service support Fiber lasers for laser welding of batteries UV Lasers for OLED manufacturing Laser systems, processing heads, and tools Laser components, optics, crystals Ceramics, thermo-electrics, rare metals Silicon carbide for power electronics OLED displays Electric vehicles Additive manufacturing Shrinking integrated circuits Megatrends $28B TAM CAGR 13% Value proposition Products Market Size Note: TAM based on CY2022; CAGR based on 2022-27 timeframe.

The Communications Market Largest supplier of optical communications components Vertically integrated from material through subsystems Industry pioneer in broad range of technology platforms Industry leading investments in R&D Global and flexible manufacturing footprint 100 to 800 Gbps Datacom Transceivers Pluggable Coherent Transceivers Wavelength Selective Switches (WSS) Pluggable Optical Line Subsystem (POLS) Terrestrial and Submarine Pump Lasers InP Edge Emitting Lasers and GaAs VCSELs Cloud AI, ML 5G Wireless Open systems Megatrends $21B TAM CAGR 12% Products Market Size Value proposition Note: TAM based on CY2022; CAGR based on 2022-27 timeframe.

The Electronics Market Broadest portfolio optoelectronics, optics, and electronics High-volume consumer electronics experience 6 inch gallium arsenide platform 200 mm silicon carbide platform World-class indium phosphide platform Decades of investment in high quality silicon carbide substrates Investing $1 billion over the next 10 years in silicon carbide Cross-functional engineering and integration expertise GaAs and InP optoelectronics VCSELs and edge emitting lasers Laser illumination modules Wafer level optics and subassemblies Waveguide materials, diffractive optics Silicon carbide substrates and epiwafers GaN/SiC HEMT and SiC MOSFET Devices 5G Wireless Electric vehicles 3D sensing, AR/VR Automotive sensing Wearable health devices Megatrends $11B TAM CAGR 17% Products Market Size Value proposition Note: TAM based on CY2022; CAGR based on 2022-27 timeframe.

The Instrumentation Market Biotechnology, medical, scientific segment solutions Custom solutions from proof-of-concept to manufacturing at scale Rapid time to market of complete turnkey systems or subsystems Broad product portfolio to support a wide range of applications Extensive technology innovation for next-generation capabilities Global manufacturing footprint and flexible supply chain partners Lasers, optics, and thermoelectrics Materials, components to subassemblies and subsystems Optical, mechanical, electrical and software integration ISO 9001 & 13485 Point-of-care diagnostics DNA sequencing Personalized medicine Environmental sustainability Megatrends Products Market Size $5B TAM CAGR 7% Value proposition Note: TAM based on CY2022; CAGR based on 2022-27 timeframe.

Coherent Acquisition

Significant Value Creation Potential from Coherent Synergies Expected Synergies within 3 years Cost of Goods Sold Supply chain management – procurement Infeed – Internal supply of enabling materials and components Operational efficiencies at scale $150M Operating Expenses More efficient R&D with scale Development cost savings Consolidation of corporate costs Global functional model efficiencies $100M TOTAL $250M

Well Capitalized for Future Growth1 External Financing Sources Debt $4.00 billion senior secured facilities allocated and priced $990 million notes issued Convertible Preferred Equity $2.15 billion commitment from Bain Capital, $750 million of which has been received Coupon: 5%, 4-year payable-in-kind, cash pay option thereafter Conversion price of $85.00 per share Pro Forma Leverage Total Debt $5.0 billion3.6x(1) Cash $0.8 billion Net Debt $4.2 billion3.0x(1) PF Combined TTM Adj EBITDA $1,407 million (incl. $250M synergies) Reflects, as of 6/30/2022, proforma combined EBITDA at 6/30/22, including $250 million of cost synergies. Cash is reflected proforma combined for 6/30/22 with adjustments made for closing transactions. Fully-Diluted Shares II-VI basic shares 106.5M Stock comp shares 5.8M Series A preferred debt 8.9M Convertible debt 7.3M Shares issued to Coherent 22.6M Series B preferred 25.9M Pro forma FDSO 177.0M

Financial Appendix

End Market Distribution of Full Year FY21 Revenue Reported Segments FY21 Revenue FY21 Op Margin – GAAP / Non-GAAP FY21/FY20 Revenue Growth Proforma(1) FY21/FY20 Revenue Growth Communica-tions Industrial Aerospace & Defense Semi Cap Life Sciences, Consumer, Automotive, Other Photonic Solutions $2,038M 10% / 16% 31% 12% 94% 3% 0% 1% 2% Compound Semiconductors $1,068M 21% / 26% 30% 30% 13% 26% 19% 10% 32% II-VI Consolidated $3,106M 13% / 19% 31% 18% 66% 10% 7% 4% 13% (1) Pro Forma calculation in accordance with ASC 805. II-VI Segment Revenue by End Markets for Full Year FY21

End Market Distribution of Q4FY22 QTD Revenue Reported Segments Q4FY21 Revenue Q4FY22 Revenue Q4FY22 Op Margin – GAAP / Non-GAAP Q4FY22/ Q4FY21 Revenue Growth Communica-tions Industrial Aerospace & Defense Semi Cap Life Sciences, Consumer, Automotive, Other Photonic Solutions $550M $597M 12% / 15% 9% 94% 3% 0% 1% 2% Compound Semiconductors $258M $290M 18% / 27% 12% 10% 31% 17% 14% 28% II-VI Consolidated $808M $887M 13% / 19% 10% 66% 12% 5% 5% 12% II-VI Segment Revenue by End Markets for Q4FY22 QTD

End Market Distribution of Full Year FY22 Revenue Reported Segments FY21 Revenue FY22 Revenue FY22 Op Margin – GAAP / Non-GAAP FY22/FY21 Revenue Growth Communica-tions Industrial Aerospace & Defense Semi Cap Life Sciences, Consumer, Automotive, Other Photonic Solutions $2,038M $2,226M 10% / 15% 9% 93% 3% 0% 1% 3% Compound Semiconductors $1,068M $1,090M 20% / 29% 2% 11% 31% 17% 13% 28% II-VI Consolidated $3,106M $3,317M 13% / 20% 7% 66% 12% 6% 5% 11% II-VI Segment Revenue by End Markets for Full Year FY22

Mapping Into Four Markets COMMUNICATIONS INDUSTRIAL INSTRUMENTATION Precision Manufacturing Semiconductor Capital Equipment Display Capital Equipment Aerospace & Defense Communications Life Sciences Scientific Instrumentation ELECTRONICS Wireless Consumer Electronics Automotive Communications Optical Communications Wireless Precision Manufacturing Microelectronics Instrumentation Industrial Semiconductor Capital Equipment Life Sciences Consumer Electronics Automotive COMBINED Aerospace & Defense Aerospace & Defense

FY22 Revenue by FY23 Market Segments End Market Distribution of Full Year FY22 Revenue Companies FY22 Revenue Communications Industrial Electronics Instrumentation II-VI Incorporated $3,317M 65% 21% 10% 4% Coherent, Inc.(1) $1,520M(1) 0% 75% 0% 25% Proforma Combined(2) $4,837M(2) 45% 38% 7% 10% Coherent Revenue 6/30/22 TTM. Proforma revenue combines II-VI FY22 revenue (as of FYE 6/30/22) and Coherent 6/30/22 TTM.

Hypothetical Illustration of EPS Calculation

Reconciliation of GAAP Measures to Non-GAAP Measures Reconciliation of Segment Non-GAAP Operating Income (Loss) to GAAP Segment Operating Income (Loss) $ Millions (Unaudited) Three Months Ended Year Ended Jun 30, Mar 31, Jun 30, Jun 30, Jun 30, 2022 2022 2021 2022 2021 Non-GAAP Photonic Solutions Operating Income $91.7 $81.8 $87.4 $334.4 $324.3 Share-based compensation (3.1) (8.8) (9.4) (30.9) (39.6) Amortization of acquired intangibles (16.6) (16.5) (17.3) (66.7) (69.2) Restructuring, transaction expenses and other (2.8) (1.9) (0.2) (6.7) (7.8) Photonic Solutions GAAP Operating Income $69.2 $54.6 $60.5 $230.1 $207.7 Non-GAAP Compound Semiconductors Operating Income $76.9 $90.2 $61.1 $315.8 $277.2 Share-based compensation (10.5) (9.2) (9.3) (42.2) (39.4) Amortization of acquired intangibles (3.2) (2.9) (3.3) (12.9) (13.0) Restructuring, transaction expenses, and other (5.4) (1.7) (0.8) (8.3) (3.6) Start-up costs $(6.4) $(14.6) $— $(32.3) $— Compound Semiconductors GAAP Operating Income $51.4 $61.8 $47.7 $220.1 $221.2 Non-GAAP Unallocated and Other Operating Income (Loss) $— $— $— $— $— Restructuring, transaction expenses, and other (6.4) (9.6) (11.1) (35.9) (26.8) Unallocated and Other GAAP Operating Income (Loss) $(6.4) $(9.6) $(11.1) $(35.9) $(26.8) Total GAAP Operating Income $114.2 $106.8 $97.1 $414.3 $402.1 Non-GAAP Operating Income $168.6 $172.0 $148.5 $650.2 $601.5 *Amounts may not recalculate due to rounding.

Reconciliation of GAAP Measures to Non-GAAP Measures

Reconciliation of GAAP Measures to Non-GAAP Measures Reconciliation of GAAP Measures to non-GAAP Measures $ Millions (Unaudited) Three Months Ended Year Ended Jun 30, Mar 31, Jun 30, Jun 30, Jun 30, 2022 2022 2021 2022 2021 Revenue $887.0 $827.7 $808.0 $3,316.6 $3,105.9 Gross profit on GAAP basis $326.0 $321.7 $297.8 $1,265.5 $1,177.5 Share-based compensation 0.9 1.3 3.4 5.1 12.1 Amortization of acquired intangibles (4) 9.6 9.4 9.8 38.3 38.8 Start-up costs (3) — 1.6 — 2.8 — Restructuring, transaction expenses and other (1) 6.9 1.7 0.7 9.8 6.7 Gross profit on non-GAAP basis $343.4 $335.7 $311.7 $1,321.5 $1,235.0 Operating income on GAAP basis $114.2 $106.8 $97.1 $414.3 $402.1 Share-based compensation 13.5 18.2 18.5 73.1 78.9 Start-up costs (3) 6.4 14.6 — 32.3 — Amortization of acquired intangibles 19.9 19.4 20.6 79.7 82.2 Restructuring, transaction expenses and other (1) 14.6 13.2 12.2 50.9 38.3 Operating income on non-GAAP basis $168.6 $172.0 $148.5 $650.2 $601.5

Reconciliation of GAAP Measures to Non-GAAP Measures

Note: Dollars in millions. Q1 FY20 represents quarter ending October July 28, 2019. Reconciliation of GAAP Measures to Non-GAAP Measures Three Months Ended 7/28/19 (Last Finisar Stand Alone Report)

Reconciliation of GAAP Measures to Non-GAAP Measures


Pennsylvania	001-39375	25-1214948
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, no par value	IIVI	Nasdaq Global Select Market
Series A Mandatory Convertible Preferred Stock, no par value	IIVIP	Nasdaq Global Select Market


Exhibit 99.1.		Press release dated August 24, 2022

Exhibit 99.2.		Investor Presentation

Exhibit 104		Cover Page Interactive Data File (embedded within the Inline XBRL document)